- World rank, all time
- #39,980 of 42,892
- Rank in United States
- #8,324 of 8,685
- Research works
- 125 ▲ 350% vs 2013–17
- Citations
- 1.8k 14.6 per fractional work
- Top-10% rate
- 13.9% record average 16.5%
- Open access
- 52% world 28%
What does Insmed (United States) specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.0× the share of its output that it takes of world research.
- MedicineField · 38.4 works4.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Immunology and Microbiology 3.5×
- Pharmacology, Toxicology and Pharmaceutics 2.2×
- Health Professions 2.0×
- Veterinary 1.3×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Chemistry 0.4×
- Economics, Econometrics and Finance 0.3×
- Decision Sciences 0.3×
- Mathematics 0.3×
- Dentistry 0.2×
- Computer Science 0.2×
- Engineering 0.2×
- Neuroscience 0.1×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Social Sciences 0.1×
Who are the top researchers at Insmed (United States)?
Ranked on the composite score, David Cipolla, Richard W. Chapman and Gina Eagle lead among researchers whose main affiliation is Insmed (United States).
- 1 David Cipolla United States · #657,989 worldwide 55 citations · 20 works
- 2 Richard W. Chapman United States · #894,661 worldwide 56 citations · 19 works
- 3 Gina Eagle United States · #1,078,767 worldwide 19 citations · 18 works
- 4 Walter R. Perkins United States · #1,274,091 worldwide 58 citations · 15 works
Which keywords describe research at Insmed (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Diagnosis, Treatment, Cystic Fibrosis, Epidemiology, Pulmonary Infections, Bronchiectasis, CFTR and Antibiotic Resistance.
- Bronchopulmonary Dysplasia
- Extracellular Matrix
- spirometry
- Prevention
- Fibroblast Activation Protein
- Pulmonary Drug Delivery
- Tumor Microenvironment
- Idiopathic Pulmonary Fibrosis
- Management
- Survival Prediction
- Treatment Guidelines
- Echocardiography
- Mycobacterium tuberculosis
- Endothelial Dysfunction
- Pulmonary Hypertension
- Mycobacterium avium
- Inflammation
- Bronchiectasis
- Cystic Fibrosis
- Diagnosis
- Epidemiology
- Treatment
- Pulmonary Infections
- CFTR
- Antibiotic Resistance
- Nontuberculous Mycobacteria
- Chronic Kidney Disease
- Immune Response
- Tuberculosis
- Angiogenesis
- Right Heart Assessment
- Fibrosis
- Nanoparticles
- Interstitial Lung Disease
- Inhaler Devices
- COPD
- Immunosuppression
- Transcriptional Regulation
- Heart Failure
- Rehabilitation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology11▲ 5.6×10 topics
- Diagnosis11▲ 23×7 topics
- Treatment10▲ 17×7 topics
- Cystic Fibrosis10▲ 273×2 topics
- Pulmonary Infections6▲ 195×2 topics
- Bronchiectasis6▲ 379×1 topic
- CFTR6▲ 379×1 topic
- Inflammation5▲ 5.1×13 topics
- Antibiotic Resistance5▲ 25×3 topics
- Mycobacterium avium4▲ 249×1 topic
- Nontuberculous Mycobacteria4▲ 249×1 topic
- Pulmonary Hypertension4▲ 51×2 topics
- Chronic Kidney Disease4▲ 29×3 topics
- Endothelial Dysfunction4▲ 30×5 topics
- Immune Response3▲ 12×2 topics
- Mycobacterium tuberculosis3▲ 118×1 topic
- Tuberculosis3▲ 125×1 topic
- Echocardiography3▲ 23×2 topics
- Angiogenesis3▲ 18×3 topics
- Treatment Guidelines3▲ 24×2 topics
- Right Heart Assessment2▲ 122×1 topic
- Survival Prediction2▲ 122×1 topic
- Fibrosis2▲ 23×2 topics
- Management2▲ 5.2×3 topics
- Nanoparticles2▲ 3.3×2 topics
- Idiopathic Pulmonary Fibrosis2▲ 83×1 topic
- Interstitial Lung Disease2▲ 61×1 topic
- Tumor Microenvironment2▲ 8.6×2 topics
- Inhaler Devices2▲ 143×1 topic
- Pulmonary Drug Delivery2▲ 143×1 topic
- COPD2▲ 49×1 topic
- Fibroblast Activation Protein2▲ 74×1 topic
- Immunosuppression2▲ 36×1 topic
- Prevention2▲ 7.4×2 topics
- Transcriptional Regulation2▲ 20×3 topics
- spirometry2▲ 49×1 topic
- Heart Failure2▲ 6.9×4 topics
- Extracellular Matrix1▲ 16×2 topics
- Rehabilitation1▲ 7.0×2 topics
- Bronchopulmonary Dysplasia1▲ 35×1 topic
Which research topics does Insmed (United States) publish most on?
By volume in 2022–2025: Cystic Fibrosis Research Advances, Mycobacterium research and diagnosis, Tuberculosis Research and Epidemiology and Pulmonary Hypertension Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 6 works
- 2 Mycobacterium research and diagnosis Epidemiology 4 works
- 3 Tuberculosis Research and Epidemiology Infectious Diseases 3 works
- 4 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
- 5 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
- 6 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 2 works
- 7 Peptidase Inhibition and Analysis Oncology 2 works
- 8 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 9 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
- 10 Pediatric health and respiratory diseases Emergency Medical Services 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Insmed (United States)'s research output changed?
Output in 2018–2022 was 350% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bridgewater
- Sanofi (United States)
- Linde (United States)
- Optimal Solutions (United States)
- Bausch Health (United States)
- Amarin (United States)
- Amneal (United States)
- Neurotez (United States)
- Synchronoss (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.